Learn from NIH’s Michael Salgaller on how to partner with NIH at the Seoul Bio Forum on June 22, 2026. This forum is intended to bring together South Korean biotech and pharma companies with U.S. investors, research institutions, and industry leaders. He will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions. This is a great opportunity to hear from an expert on technology transfer at the NIH.

Salgaller leads the Technology Analysis and Marketing Unit within the Technology Transfer Center at the National Cancer Institute (NCI). He has over 20 years of scientific and investment experience and is ready to help foster licensing and collaboration activities between your organization and NCI.

This in-person forum will take place at the UC San Diego Park & Market on June 22nd at 4pm alongside the Biotechnology Innovation Organization's 2026 International Convention. For registration or more information, please contact Chaperone Ventures & Seoul Bio Hub via email at jc@chaperoneventures.com.